Introduction. In the period from 2011 - 2021, 1482 gynecologic surgeries were
performed at the Department of Gynecology and Obstetrics of the General
Hospital in Sombor, of which 50 (3.4%) were gynecologic oncology surgical
procedures. The distribution of the malignant tumor localization was as
follows: vulva 4 (8%), cervix 13 (26%), endometrium 24 (48%), and ovary 9
(18%). Material and Methods. The preoperative diagnosis of all patients
included standard laboratory tests of blood and urine, chest X-ray, internal
medicine specialist examination, electrocardiography, and imaging procedures
(magnetic resonance imaging or computed tomography) of the small pelvis and
abdomen. In all cases, the diagnosis of vulvar, cervical, and endometrial
cancer was made preoperatively, based on pathohistological findings of the
biopsy samples of tumor tissue or material obtained using exploratory
curettage. In ovarian cancer, the diagnosis was made during surgery based on
ex tempore pathohistological analysis. Results. Most of the operated
patients were in the International Federation of Gynecology and Obstetrics
stage I - 39 (78%) and the most common pathohistological type of tumor was
adenocarcinoma of different localizations - 29 (58%). The number of lymph
nodes removed per surgery was 16 - 39 (x: 19) and lymphovascular invasion
was present in 31 (62%) operated patients. Intraoperative complications
(bleeding, ureteral injury, infection, and wound dehiscence) occurred in 8
(16%) patients, recurrence occurred in 3 (6%), and postoperative lethal
outcome occurred in 4 (8%) patients. Conclusion. The essential condition for
performing gynecologic oncology surgical procedures in a secondary level
healthcare facility is a well-trained gynecology surgeon who has received
complete training in gynecologic oncology at the tertiary level, as well as
the optimal number of gynecologic oncology surgeries in accordance with
recommendations of the European Society of Gynecological Oncology.
